Ketamine Completed Phase 4 Trials for Moderate, Deep Sedation Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02519595Optimal Dosing of Ketamine for Procedural Sedation and Analgesia in Children